Strikingly, however, we observed elevated levels of Myc–APL in chromatin fractions following exposure to the DNA ICL-inducing agent cisplatin, implicating APL in the response to DNA damage inflicted by this agent. The gene discussed is MYC; the disease is acute promyelocytic leukemia.